Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Expert Opinion: Management of Intraocular Inflammation and Vasculitis After Intravitreal Pegcetacoplan for Geographic Atrophy.

Ophthalmic surgery, lasers & imaging retina·2026
Same author

Plain language summary of publication of the 96-week results from the PHOTON study: intravitreal aflibercept 8 mg for diabetic macular edema.

Therapeutic advances in ophthalmology·2026
Same author

Vision-related quality of life in non-neovascular age-related macular degeneration: a protocol for systematic review and meta-analysis.

Eye (London, England)·2026
Same author

Mid-Phase Hyperfluorescent Plaques as a biomarker of disease activity in Central Serous Chorioretinopathy: Clinical Course and Treatment Response - MICRoN report number Ten.

Retina (Philadelphia, Pa.)·2026
Same author

Inherited Retinal Disease Management in the United States: A Survey of Clinician Practice Patterns.

Retina (Philadelphia, Pa.)·2026
Same author

Real-World Insights on Switching Aflibercept Dosage for Enhanced Outcomes in Retinal Vein Occlusion (RISE-RVO): visual, anatomical and durability outcomes.

The British journal of ophthalmology·2026

相关实验视频

Updated: Jan 12, 2026

An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach
07:13

An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach

Published on: December 7, 2016

13.9K

患者报告的体验和舒适度与静脉内注射技术相关:一个横截面调查方法.

Elahhe R Afkhamnejad1, Zainub A Abdullah1, Orion M Q Nguyen2

  • 1University of Texas Medical Branch Galveston, Galveston, TX, USA.

Journal of vitreoretinal diseases
|November 3, 2025
PubMed
概括

大多数患者能很好地耐受静脉内抗VEGF注射,报告的不适和副作用最小. 患者的偏好倾向于使用特定的技术,如手动收缩眼和贝塔丁浸泡的棉花尖端,以便在这些重要的眼部治疗过程中获得更好的舒适性.

关键词:
抗VEGF剂的使用者.糖尿病黄斑胀 糖尿病黄斑胀患者的满意度 患者的满意度增殖性糖尿病视网膜病变湿湿的AMD (神经血管) 的情况.

更多相关视频

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

1.6K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.2K

相关实验视频

Last Updated: Jan 12, 2026

An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach
07:13

An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach

Published on: December 7, 2016

13.9K
Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

1.6K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.2K

科学领域:

  • 眼科医生 眼科 眼科
  • 患者体验研究 研究研究
  • 医疗设备和技术分析 医疗设备和技术分析

背景情况:

  • 肠内抗VEGF注射对于治疗各种视网膜疾病至关重要.
  • 了解患者的舒适度和偏好是改善治疗坚持和治疗结果的关键.
  • 注射技术的变化可能会影响患者的体验和报告的副作用.

研究的目的:

  • 为了评估患者的经验和偏好,关于静脉内抗VEGF注射技术.
  • 识别注射过程中导致患者不适或满意的特定方面.
  • 为了比较患者报告的不同麻醉方法,盖收缩和消毒剂应用的结果.

主要方法:

  • 在五个临床地点对1111名接受抗VEGF注射的患者进行了一项调查.
  • 包括t测试,ANOVA和Tukey-Kramer测试在内的统计分析被用来比较患者的反应.
  • 收集的数据包括不适的评级,对特定技术的偏好和报告的副作用.

主要成果:

  • 患者报告的整体不适程度较低 (VAS平均值<2/10).
  • 利多卡因的承诺与更高的不适相关 (P < .05),而手动盖收缩被偏好于镜片 (P = .0017).
  • 浸泡在贝塔丁的棉花尖是首选的,而不是滴水或拭子;常见的投诉包括不充分的麻醉和贝塔丁刺激.

结论:

  • 静脉内抗VEGF注射通常耐受良好,副作用最小.
  • 患者的偏好倾向于局部凝或下麻醉,手动盖收缩,和贝塔丁浸泡的棉花尖端.
  • 对首选技术的安全性进行进一步研究是有必要的.